Please assess the completion status of the following clinical trial:

Trial Title: Symptoms of Post-traumatic Stress in Adult Drug-resistant Epilepsies

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Man or woman between 18 and 50 years old;~* Native French speaker;~* Level of education higher than the 3rd school level;~* Certain diagnosis of the pathology of the experimental group with which he will be associated, more precisely:~* Group of patients with epilepsy \[Group E\]: definite diagnosis of drug-resistant epilepsy (epileptic seizures persist despite the administration of daily treatment) established by a specialist physician.~* Group of patients with a heart rhythm disorder \[Group C\]: definite diagnosis of one of the following disorders: Atrial Fibrillation (AF); Syncope and Bouveret's disease established by a specialist.~* Group of patients with T1 diabetes mellitus \[Group D\]: definite diagnosis of type 1 diabetes established by a specialist doctor.~* Group of patients with PTSD \[Group T\]: definite diagnosis of PTSD established by a specialist doctor.~* Person having given his non-objection~Exclusion Criteria:~* Pregnancy;~* Breastfeeding women;~* Severe cognitive impairment~* Addiction to alcohol or drugs (including drugs other than those related to epilepsy or the chronic disease from which the patient has);~* Other neurological and / or psychiatric disorders than CNEP or epilepsy except anxiety and depressive disorders;~* Adults under guardianship or under judicial protection~* People deprived of their liberty~* Inability to read French.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Patients with epilepsy (Type: OTHER): None
- Patients with PTSD (Type: OTHER): None
- Patients with type 1 diabetes (Type: OTHER): None
- Patients with a heart rhythm disorder (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).